Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy

Novel targeted therapies for metastatic colorectal cancer are needed to personalize treatments by guiding specific biomarkers selected on the genetic profile of patients. RAS and BRAF inhibitors have been developed for patients who become unresponsive to standard therapies. Sotorasib and adagrasib s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosati, Gerardo, Aprile, Giuseppe, Colombo, Alfredo, Cordio, Stefano, Giampaglia, Marianna, Cappetta, Alessandro, Porretto, Concetta Maria, De Stefano, Alfonso, Bilancia, Domenico, Avallone, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138254/
https://www.ncbi.nlm.nih.gov/pubmed/35625772
http://dx.doi.org/10.3390/biomedicines10051035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138254/
https://www.ncbi.nlm.nih.gov/pubmed/35625772
http://dx.doi.org/10.3390/biomedicines10051035

Ejemplares similares